Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival

Table 1 Baseline characteristics of the 34 patients with early hepatocellular carcinoma treated with radio frequency ablation n (%)

Characteristics	No. of patients (n = 34)
Sex, male/female	26/8
Age in years median, range	63, 49-84
Etiology,
HCV	24 (70)
HBV	1 (3)
Alcohol	6 (18)
Others	3 (9)
Child-Pugh class
A	26 (76)
B	8 (24)
MELD points median, range	9, 6-16
Cutpoint by Lausen method	11
Portal hypertension, n (%)	27 (79)
ECOG-PST, 0/1 %	85/15
BCLC stage, 0/A %	18/82
Alpha-fetoprotein in ng/mL median, range	10.7, 1.4-12.7
Tumor size in mm, median, range	26, 10-50
Cutpoint by Lausen method	35
Tumor stage, n (%)
Single	22 (65)
≤ 20 mm	6
21-30 mm	8
> 30 mm	8
Multinodular	12 (35)
Initial response (n = 32)
Complete	29 (90)
Partial	3 (10)
Recurrence (n = 32)
No	17 (53)
Yes	15 (47)
Local tumor recurrence	6
Distant recurrence	9

HCV: Hepatitis C Virus; HBV: Hepatitis B Virus; MELD: Model for end-stage liver disease.